StockClub

INBP

INBPIntegrated BioPharma, Inc.$ --
Integrated BioPharma, Inc.

Integrated BioPharma, Inc.

INBP

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q3
Revenue
10M USD
YoY -27.5%
Operating Income
-1M USD
YoY -246.8%
Net Income
-1M USD
YoY -237.0%
EPS
-0.03$
YoY -233.7%

Revenue

$34.1M
FY2024 Q4$62.4M
$62.4M
Q4
FY2025 Q1$13.6M
$13.6M
Q1
FY2025 Q2$26.2M
$26.2M
Q2
FY2025 Q3$40.2M
$40.2M
Q3
FY2025 Q4$54.4M
$54.4M
Q4
FY2026 Q1$12.7M
$12.7M
Q1
FY2026 Q2$24M
$24M
Q2
FY2026 Q3$34.1M
$34.1M
Q3
Actual
$-6.1M (-15.2%)

Net Income

$-1.5M
FY2024 Q4$112,000
$112,000
Q4
FY2025 Q1$259,000
$259,000
Q1
FY2025 Q2$375,000
$375,000
Q2
FY2025 Q3$986,000
$986,000
Q3
FY2025 Q4$808,000
$808,000
Q4
FY2026 Q1$123,000
$123,000
Q1
FY2026 Q2$-639,000
$-639,000
Q2
FY2026 Q3$-1.5M
$-1.5M
Q3
Actual
$-2.5M (-249.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$52.8M
FY2020
$52.8M
FY2021
Actual:$63.6M
FY2021
$63.6M
FY2022
Actual:$56.2M
FY2022
$56.2M
FY2023
Actual:$50.7M
FY2023
$50.7M
FY2024
Actual:$50.3M
FY2024
$50.3M
FY2025
Actual:$54.4M
FY2025
$54.4M

Analyst Estimates

No forecast data